June 11, 2014

You are subscribed to the Optometry Times eNews.

Optometry Times News Flash

Web Version  |  Digital Edition  |  Share with a colleague   |   Digital Subscribe  |   Print Subscribe   |   eNews Subscribe

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Study: using Avastin to treat AMD, DME could save Medicare billions

Ann Arbor, MI—A study from the University of Michigan, which was recently published in Health Affairs, found that if all eyecare practitioners (ECPs) prescribed Avastin (bevacizumab, Genentech) patient instead of the more-expensive Lucentis (ranibizumab, Genentech) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME), Medicare plans could save $18 billion over a 10-year period. » More

FDA advisory panel says benefits of KAMRA inlay outweigh risks

Irvine, CA—The U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel recently determined that the benefits of AcuFocus’ KAMRA inlay outweigh the risks for presbyopic patients. » More

BCLA names new president, announces winner of BCLA Industry Award

Coventry, UK—The British Contact Lens Association recently welcomed Susan Bowers as its president for 2014-15. The new president elect is Brian Tompkins. » More

AAOphth offers answers to common questions about cataracts

San Francisco—In honor of Cataract Awareness Month in June, the American Academy of Ophthalmology has provided answers to 250 commonly asked questions about cataracts. » More

 

CONNECT WITH Optometry Times

Join your colleagues in conversation, respond to hot-topic questions, and stay up to date on breaking news. Like and follow us today!

Facebook

» Facebook

Facebook

» Twitter

Powered by Modern Medicine Advanstar Medical Communications Group